1.        Introduction

1.1      The Insight Partners Research Report Guidance

1.2      Market Segmentation

2.        Executive Summary

2.1      Key Insights

3.        Research Methodology

3.1      Secondary Research

3.2      Primary Research

3.2.1       Hypothesis formulation:

3.2.2       Macro-economic factor analysis:

3.2.3       Developing base number:

3.2.4       Data Triangulation:

3.2.5       Country level data:

4.        South & Central America Gastrointestinal Drugs Market Landscape

4.1      Overview

4.2      PEST Analysis

5.        South & Central America Gastrointestinal Drugs Market – Key Market Dynamics

5.1      Market Drivers

5.1.1       Rising Cases of Gastrointestinal Diseases

5.1.2       Increasing Development of Biologics

5.2      Market Restraints

5.2.1       High Cost of Biologics

5.2.2       Average Cost of Biologic Drugs for Severe Ulcerative Colitis or Crohn's Disease

5.3      Market Opportunities

5.3.1       Strategic Initiatives by Companies

5.4      Future Trends

5.4.1       Increasing Research Investment for Novel Drug Development and Artificial Intelligence-Based Techniques

5.5      Impact of Drivers and Restraints:

6.        Gastrointestinal Drugs Market – South & Central America Analysis

6.1      South & Central America Gastrointestinal Drugs Market Revenue (US$ Million), 2021–2031

7.        South & Central America Gastrointestinal Drugs Market Analysis – by Drug Class

7.1      Biologics

7.1.1       Overview

7.1.2       Biologics: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

7.2      Antidiarrheal and Laxatives

7.2.1       Overview

7.2.2       Antidiarrheal and Laxatives: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031  (US$ Million)

7.3      Acid Neutralizers

7.3.1       Overview

7.3.2       Acid Neutralizers: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

7.4      Anti-inflammatory Drugs

7.4.1       Overview

7.4.2       Anti-inflammatory Drugs: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

7.5      Antiemetic and Antinauseants

7.5.1       Overview

7.5.2       Antiemetic and Antinauseants: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031  (US$ Million)

7.6      Others

7.6.1       Overview

7.6.2       Others: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

8.        South & Central America Gastrointestinal Drugs Market Analysis – by Application

8.1      Irritable Bowel Syndrome

8.1.1       Overview

8.1.2       Irritable Bowel Syndrome: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

8.2      Inflammatory Ulcerative Colitis

8.2.1       Overview

8.2.2       Inflammatory Ulcerative Colitis: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031  (US$ Million)

8.3      Crohn’s Disease

8.3.1       Overview

8.3.2       Crohn’s Disease: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

8.4      Gastroenteritis

8.4.1       Overview

8.4.2       Gastroenteritis: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

8.5      Celiac Disease

8.5.1       Overview

8.5.2       Celiac Disease: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

8.6      Others

8.6.1       Overview

8.6.2       Others: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

9.        South & Central America Gastrointestinal Drugs Market Analysis – by Route of Administration

9.1      Oral

9.1.1       Overview

9.1.2       Oral: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

9.2      Parenteral

9.2.1       Overview

9.2.2       Parenteral: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

10.      South & Central America Gastrointestinal Drugs Market Analysis – by Distribution Channel

10.1    Hospital Pharmacies

10.1.1     Overview

10.1.2     Hospital Pharmacies: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

10.2    Retail Pharmacies

10.2.1     Overview

10.2.2     Retail Pharmacies: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

10.3    Online Pharmacies

10.3.1     Overview

10.3.2     Online Pharmacies: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

11.      South & Central America Gastrointestinal Drugs Market – Country Analysis

11.1    South & Central America

11.1.1     South & Central America Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Country

11.1.1.1       Brazil: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

11.1.1.1.1      Brazil: South & Central America Gastrointestinal Drugs Market Breakdown, by Drug Class

11.1.1.1.2      Brazil: South & Central America Gastrointestinal Drugs Market Breakdown, by Application

11.1.1.1.3      Brazil: South & Central America Gastrointestinal Drugs Market Breakdown, by Route Of Administration

11.1.1.1.4      Brazil: South & Central America Gastrointestinal Drugs Market Breakdown, by Distribution Channel

11.1.1.2       Argentina: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

11.1.1.2.1      Argentina: South & Central America Gastrointestinal Drugs Market Breakdown, by Drug Class

11.1.1.2.2      Argentina: South & Central America Gastrointestinal Drugs Market Breakdown, by Application

11.1.1.2.3      Argentina: South & Central America Gastrointestinal Drugs Market Breakdown, by Route Of Administration

11.1.1.2.4      Argentina: South & Central America Gastrointestinal Drugs Market Breakdown, by Distribution Channel

11.1.1.3       Rest of South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

11.1.1.3.1      Rest of South & Central America Gastrointestinal Drugs Market Breakdown, by Drug Class

11.1.1.3.2      Rest of South & Central America Gastrointestinal Drugs Market Breakdown, by Application

11.1.1.3.3      Rest of South & Central America Gastrointestinal Drugs Market Breakdown, by Route Of Administration

11.1.1.3.4      Rest of South & Central America Gastrointestinal Drugs Market Breakdown, by Distribution Channel

12.      Industry Landscape

12.1    Overview

12.2    Growth Strategies in South & Central America Gastrointestinal Drugs Market

12.3    Organic Growth Strategies

12.3.1     Overview

12.4    Inorganic Growth Strategies

12.4.1     Overview

13.      Company Profiles

13.1    Sanofi SA

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2    GSK Plc

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3    Johnson & Johnson

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4    Bausch Health Companies Inc

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5    AstraZeneca Plc

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6    Takeda Pharmaceutical Co Ltd

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7    AbbVie Inc

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8    Bayer AG

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9    Pfizer Inc

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

14.      Appendix

14.1    About The Insight Partners

14.2    Glossary of Terms

List of Tables

Table 1.          South & Central America Gastrointestinal Drugs Market Segmentation

Table 2.          Brazil: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 3.          Brazil: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 4.          Brazil: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration

Table 5.          Brazil: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel

Table 6.          Argentina: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 7.          Argentina: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 8.          Argentina: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration

Table 9.          Argentina: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel

Table 10.        Rest of South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 11.        Rest of South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 12.        Rest of South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration

Table 13.        Rest of South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel

Table 14.        Recent Organic Growth Strategies in South & Central America Gastrointestinal Drugs Market

Table 15.        Recent Inorganic Growth Strategies in the South & Central America Gastrointestinal Drugs Market

Table 16.        Glossary of Terms, South & Central America Gastrointestinal Drugs Market

List of Figures

Figure 1.         South & Central America Gastrointestinal Drugs Market Segmentation, by Country

Figure 2.         PEST Analysis

Figure 3.         South & Central America Gastrointestinal Drugs Market – Key Market Dynamics

Figure 4.         Impact Analysis of Drivers and Restraints

Figure 5.         South & Central America Gastrointestinal Drugs Market Revenue (US$ Million), 2021–2031

Figure 6.         South & Central America Gastrointestinal Drugs Market Share (%) – by Drug Class (2023 and 2031)

Figure 7.         Biologics: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 8.         Antidiarrheal and Laxatives: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 9.         Acid Neutralizers: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 10.      Anti-inflammatory Drugs: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 11.      Antiemetic and Antinauseants: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 12.      Others: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 13.      South & Central America Gastrointestinal Drugs Market Share (%) – by Application (2023 and 2031)

Figure 14.      Irritable Bowel Syndrome: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 15.      Inflammatory Ulcerative Colitis: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 16.      Crohn’s Disease: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 17.      Gastroenteritis: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 18.      Celiac Disease: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 19.      Others: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 20.      South & Central America Gastrointestinal Drugs Market Share (%) – by Route of Administration (2023 and 2031)

Figure 21.      Oral: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 22.      Parenteral: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 23.      South & Central America Gastrointestinal Drugs Market Share (%) – by Distribution Channel (2023 and 2031)

Figure 24.      Hospital Pharmacies: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 25.      Retail Pharmacies: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 26.      Online Pharmacies: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 27.      South & Central America Gastrointestinal Drugs Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 28.      South & Central America Gastrointestinal Drugs Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 29.      Brazil: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)

Figure 30.      Argentina: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)

Figure 31.      Rest of South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)

Figure 32.      Growth Strategies in South & Central America Gastrointestinal Drugs Market